| Association of musculoskeletal complaints and gliptin use: review of spontaneous reports M Tarapués, G Cereza, A Figueras Pharmacoepidemiology and drug safety 22 (10), 1115-1118, 2013 | 45 | 2013 |
| Serious QT interval prolongation with ranolazine and amiodarone M Tarapués, G Cereza, AL Arellano, E Montané, A Figueras International journal of cardiology 172 (1), e60-e61, 2014 | 21 | 2014 |
| Medicamentos sobrantes y caducados en el hogar¿ su almacenaje y desecho representan un problema de salud pública? JM Calderón, M Tarapués Salud colectiva 17, e3599, 2022 | 19 | 2022 |
| Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study LC Lopes, M Salas, CGS Osorio‐de‐Castro, LF Leal, SV Doubova, ... Pharmacoepidemiology and drug safety 31 (3), 343-352, 2022 | 10 | 2022 |
| Prevalencia de factores de riesgo para tromboembolismo venoso en pacientes hospitalizados: estudio multicéntrico en cinco hospitales de la ciudad de Quito-Ecuador P Merchán, N Cevallos, M Tarapués Rev Med Vozandes 23 (1), 23-9, 2012 | 10 | 2012 |
| Conductas de autocuidado en pacientes ambulatorios con insuficiencia cardíaca crónica M Tarapués, M Albán, M Arévalo, JP Paredes Rev Med Vozandes 29 (67-72), 2018 | 6 | 2018 |
| Dronedarone and renal impairment: evaluation of Spanish postmarketing reports and review of literature M Tarapués, G Cereza, A Figueras Expert Opinion on Drug Safety 14 (6), 807-813, 2015 | 5 | 2015 |
| New statins also produce fatigue: spontaneous reporting as a complementary system to increase safety knowledge M Tarapués, G Cereza, A Figueras JAMA internal medicine 173 (3), 247-248, 2013 | 4 | 2013 |
| Leftover and expired medicines in households: Is their storage and disposal a public health problem? JM Calderón, M Tarapués Salud Colectiva 17, e3599, 2022 | 2 | 2022 |
| Data sources for drug utilization research in Latin American (LatAm) countries LC Lopes, M Salas, CGS Osorio-de-Castro, A Acosta, M Crisante, ... Pharmacoepidemiology and Drug Safety 28 (2, SI), 110-111, 2019 | 2 | 2019 |
| Monitoring and analysis of adverse reactions associated with medicines recently approved for treatment of cardiovascular disease collected through the spontaneous reporting system MN Tarapués Román Universitat Autònoma de Barcelona,, 2015 | 1 | 2015 |
| The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs) MA Elhawary, CK Ogar, M Tarapués, A Caro, HB Ndagije, G Benabdallah, ... Drug Safety 46 (12), 1307-1312, 2023 | | 2023 |
| Developing Practical Pharmacovigilance Skills at a Distance: Description and Evaluation of UMC's Instructor-Led Online Learning N Jastrebova, E Sollenbring, M Tarapues, R Savage Drug Safety 45 (10), 1294-1295, 2022 | | 2022 |
| Ecuador's administrative data sources for drug utilization research M Tarapues, C Duran, B Mena, P Granja, L Leal, M Elseviers, L Cruz PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 166-167, 2020 | | 2020 |
| Atorvastatin/dronedarone/eplerenone/ranolazine/tacrolimus M Tarapues Reactions 1582, 69-19, 2015 | | 2015 |
| Amiodarone/ranolazine interaction M Tarapues Reactions 1524, 29-25, 2014 | | 2014 |
| The Webreporting Format to Report Adverse Drug Reactions in Latin-American Countries-an Affordable Way to Overcome the Underreporting M Tarapues, G Cereza, A Figueras DRUG SAFETY 36 (9), 845-846, 2013 | | 2013 |
| INFORMACIÓN OTORGADA SOBRE MEDICAMENTOS A LOS PACIENTES DE LA CONSULTA AMBULATORIA: DATOS PARCIALES DEL COMPONENTE ECUADOR DEL ESTUDIO LATINOAMERICANO. M Tarapués, F Santos, JC Maldonado | | |
